stigmasterol

Stigmasterol (Stigmasterin) is a phytosterol with major functions in the maintenance of cell membrane structure and physiology. Stigmasterol lowers cholesterol levels and has anti-tumor, anti-inflammatory, and immunomodulatory effects.

Glucosyl stigmasterol is a glycosylated sterol.

Stigmasterol (Standard) is a reference standard for research and analysis in studies involving Stigmasterol. Stigmasterol (Stigmasterin) is a phytosterol with major functions in the maintenance of cell membrane structure and physiology. Stigmasterol lowers cholesterol levels and has anti-tumor, anti-inflammatory, and immunomodulatory effects.

Stigmasterol glucoside is a natural sterol and 5α-reductase inhibitor (IC50=27.2 µM) with potential antioxidant and antitumor properties.

7alpha-Hydroxystigmasterol is a natural product of Xanthium, Asteraceae. The catalog number is TN3254 and the CAS number is 64998-19-2. 7alpha-Hydroxystigmasterol can be used as a reference standard.

Beta-Sitosterol (SKF 14463) has recently been shown to induce G2/M arrest, endoreduplication, and apoptosis through the Bcl-2 and PI3K/Akt signaling pathways. Beta-Sitosterol (SKF 14463) , a main dietary phytosterol found in plants, may have the potential for prevention and therapy for human cancer. Although the exact mechanism of action of Beta-Sitosterol (SKF 14463) is unknown, it may be related to cholesterol metabolism or anti-inflammatory effects (via interference with prostaglandin metabolism). Beta-Sitosterol (SKF 14463) induces apoptosis and activates key caspases in MDA-MB-231 human breast cancer cells.

Beta-Sitosterol (Standard) is a ubiquitous phytosterol structurally related to cholesterol that is widely distributed in the plant kingdom and found in high concentrations in vegetable oils, nuts, and legumes where it serves as a key functional ingredient for the formulation of dietary supplements and functional foods designed to modulate lipid metabolism through the competitive inhibition of intestinal cholesterol absorption across various preclinical experimental models.

Vomifoliol is a plant-derived compound likely serving as the immediate precursor of dehydrovomifoliol due to its metabolic conversion from abscisic acid. Vomifoliol, in conjunction with Stigmasterol, exhibits antiproliferative activity on human lung cancer cell lines, making Vomifoliol relevant in studies of plant metabolite biotransformation and anticancer bioactivity.